Sonya Montgomery, BASc, ND
Chief Development Officer
Dr Sonya Montgomery leads advancement of Tangram’s clinical pipeline. She has over 25 years’ experience designing and executing portfolio and development strategies, from translational research through registration. Her work spans a wide range of therapeutic areas and modalities, including genetic medicines, across both pharma and biotech. Following her training in engineering and medicine in Canada, Dr Montgomery held global leadership positions at Pfizer and has subsequently served as Vice President Clinical Development at ProQR, Vice President and Head of Clinical Development at Gyroscope Therapeutics, Chief Medical Officer at Evox Therapeutics, and, most recently, Chief Development Officer at OSE Immunotherapeutics.
